SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000939798-19-000019
Filing Date
2019-04-19
Accepted
2019-04-19 16:23:09
Documents
1
Period of Report
2019-04-19
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 GTBP 8-K ITEM 3.02 gtbpeightkthreepttwo.htm 8-K 11194
  Complete submission text file 0000939798-19-000019.txt   12586
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 19758114
SIC: 2834 Pharmaceutical Preparations